AGP Picks
View all

Guyana Health Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guyana Health Review.

Press releases published on August 20, 2026

Herantis Pharma releases 1H 2026 report today
George Medicines announces GMRx2 presentations at the European Society of Cardiology Congress 2026
Why Work With Transcom: Disability Inclusion Recognized for a Second Year
Verano Enters Cannabis Beverage Category with Debut of Easy Landings, Company’s First National Beverage Brand Featuring Four Delicious Flavors and All-Natural Ingredients
Nurix Therapeutics Announces Appointment of Wes Burwell  as Chief Human Resources Officer
NetraMark Corporate Update Highlights Record C$3.4 Million in Fiscal 2026 Contract Bookings, Up 645% from Previous Annual High
Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
Grey Matters Announces CAD $800K of Private Placement Equity Financing and Convertible Debentures
Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections
Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution
UroGen Announces Strategic Collaboration and Investment Agreements with IntraGel to Access Biodegradable Sustained-Release Gel Platform and Expand Oncology Pipeline
HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK
Global Cardiovascular Devices Market to Reach $101.6 Billion by 2030, Says BCC Research Analyst
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement
BioNTech präsentiert auf der WCLC 2026 Fortschritte ihrer spätklinischen Pipeline bei Lungenkrebs und erste globale Daten zur innovativen Behandlungskombination aus Pumitamig und Elfetabart Drozuntecan
BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement
Edesa Biotech Announces Pricing of $25.0 Million Public Offering

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guyana Health Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.